Santhera Pharmaceuticals Holding AG - Company Profile
Powered by 
All the sales intelligence you need on Santhera Pharmaceuticals Holding AG in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Santhera Pharmaceuticals Holding AG fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Santhera Pharmaceuticals Holding AG.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Santhera Pharmaceuticals Holding AG (Santhera) is a Swiss specialty pharmaceutical company. The company focuses on the discovery, development and marketing of novel pharmaceutical products for the treatment of orphan neuromuscular and mitochondrial diseases. The company capitalizes on its expertise in R&D activities, strong global partnerships, and performance of its lead product Agamree, even as, dependency on limited number of drug candidates is a cause of concern for the company. Santhera could benefit from regulatory approvals, strategic agreements, and unmet medical needs for Duchenne Muscular Dystrophy. However, regulatory challenges and compliance, competitive pressures, and uncertainties from the ongoing R&D activities could hamper its business.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer